The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Mumps-Global Market Insights and Sales Trends 2024

Mumps-Global Market Insights and Sales Trends 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1851527

No of Pages : 87

Synopsis
Mumps is a contagious disease typically affecting children and caused by the mumps virus. The characteristic of this disease is the initial onset of headache, loss of appetite, muscle aches, tiredness and fever followed by the typical swelling of one or more salivary glands.
The global Mumps market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Mumps in various end use industries. The expanding demands from the Hospital Pharmacies, Retail Pharmacies and Institutional Centers,, are propelling Mumps market. Preventive Therapies, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Curative Therapies segment is estimated at % CAGR for the next seven-year period.
North America is expected to lead the mumps market, owing to higher rates of vaccination coupled with the expensive cost of vaccination and treatment.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Mumps, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Mumps market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Mumps market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Mumps sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Mumps covered in this report include GlaxoSmithKline, Serum Institute of India, Merck, Sanofi and Tiantan Bio, etc.
The global Mumps market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GlaxoSmithKline
Serum Institute of India
Merck
Sanofi
Tiantan Bio
Global Mumps market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Mumps market, Segment by Type:
Preventive Therapies
Curative Therapies
Global Mumps market, by Application
Hospital Pharmacies
Retail Pharmacies
Institutional Centers
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Mumps companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index
1 Market Overview of Mumps
1.1 Mumps Market Overview
1.1.1 Mumps Product Scope
1.1.2 Mumps Market Status and Outlook
1.2 Global Mumps Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Mumps Market Size by Region (2018-2029)
1.4 Global Mumps Historic Market Size by Region (2018-2023)
1.5 Global Mumps Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Mumps Market Size (2018-2029)
1.6.1 North America Mumps Market Size (2018-2029)
1.6.2 Europe Mumps Market Size (2018-2029)
1.6.3 Asia-Pacific Mumps Market Size (2018-2029)
1.6.4 Latin America Mumps Market Size (2018-2029)
1.6.5 Middle East & Africa Mumps Market Size (2018-2029)
2 Mumps Market by Type
2.1 Introduction
2.1.1 Preventive Therapies
2.1.2 Curative Therapies
2.2 Global Mumps Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Mumps Historic Market Size by Type (2018-2023)
2.2.2 Global Mumps Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Mumps Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Mumps Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Mumps Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Mumps Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Mumps Revenue Breakdown by Type (2018-2029)
3 Mumps Market Overview by Application
3.1 Introduction
3.1.1 Hospital Pharmacies
3.1.2 Retail Pharmacies
3.1.3 Institutional Centers
3.2 Global Mumps Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Mumps Historic Market Size by Application (2018-2023)
3.2.2 Global Mumps Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Mumps Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Mumps Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Mumps Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Mumps Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Mumps Revenue Breakdown by Application (2018-2029)
4 Mumps Competition Analysis by Players
4.1 Global Mumps Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Mumps as of 2022)
4.3 Date of Key Players Enter into Mumps Market
4.4 Global Top Players Mumps Headquarters and Area Served
4.5 Key Players Mumps Product Solution and Service
4.6 Competitive Status
4.6.1 Mumps Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 GlaxoSmithKline
5.1.1 GlaxoSmithKline Profile
5.1.2 GlaxoSmithKline Main Business
5.1.3 GlaxoSmithKline Mumps Products, Services and Solutions
5.1.4 GlaxoSmithKline Mumps Revenue (US$ Million) & (2018-2023)
5.1.5 GlaxoSmithKline Recent Developments
5.2 Serum Institute of India
5.2.1 Serum Institute of India Profile
5.2.2 Serum Institute of India Main Business
5.2.3 Serum Institute of India Mumps Products, Services and Solutions
5.2.4 Serum Institute of India Mumps Revenue (US$ Million) & (2018-2023)
5.2.5 Serum Institute of India Recent Developments
5.3 Merck
5.3.1 Merck Profile
5.3.2 Merck Main Business
5.3.3 Merck Mumps Products, Services and Solutions
5.3.4 Merck Mumps Revenue (US$ Million) & (2018-2023)
5.3.5 Sanofi Recent Developments
5.4 Sanofi
5.4.1 Sanofi Profile
5.4.2 Sanofi Main Business
5.4.3 Sanofi Mumps Products, Services and Solutions
5.4.4 Sanofi Mumps Revenue (US$ Million) & (2018-2023)
5.4.5 Sanofi Recent Developments
5.5 Tiantan Bio
5.5.1 Tiantan Bio Profile
5.5.2 Tiantan Bio Main Business
5.5.3 Tiantan Bio Mumps Products, Services and Solutions
5.5.4 Tiantan Bio Mumps Revenue (US$ Million) & (2018-2023)
5.5.5 Tiantan Bio Recent Developments
6 North America
6.1 North America Mumps Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Mumps Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Mumps Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Mumps Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Mumps Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Mumps Market Dynamics
11.1 Mumps Industry Trends
11.2 Mumps Market Drivers
11.3 Mumps Market Challenges
11.4 Mumps Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

Published By : QY Research

Why ‘The Market Reports’